[go: up one dir, main page]

ZA949929B - Sugar-coated pharmaceutical dosage unit. - Google Patents

Sugar-coated pharmaceutical dosage unit.

Info

Publication number
ZA949929B
ZA949929B ZA949929A ZA949929A ZA949929B ZA 949929 B ZA949929 B ZA 949929B ZA 949929 A ZA949929 A ZA 949929A ZA 949929 A ZA949929 A ZA 949929A ZA 949929 B ZA949929 B ZA 949929B
Authority
ZA
South Africa
Prior art keywords
sugar
dosage unit
pharmaceutical dosage
coated pharmaceutical
steroid
Prior art date
Application number
ZA949929A
Other languages
English (en)
Inventor
Pieter De Haan
Marcus Johannes Maria Deurloo
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA949929B publication Critical patent/ZA949929B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
ZA949929A 1993-12-23 1994-12-13 Sugar-coated pharmaceutical dosage unit. ZA949929B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93203645 1993-12-23

Publications (1)

Publication Number Publication Date
ZA949929B true ZA949929B (en) 1995-08-23

Family

ID=8214236

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA949929A ZA949929B (en) 1993-12-23 1994-12-13 Sugar-coated pharmaceutical dosage unit.

Country Status (16)

Country Link
US (1) US5662936A (de)
EP (1) EP0659432B1 (de)
JP (1) JPH07206681A (de)
KR (1) KR100330560B1 (de)
CN (1) CN1108929A (de)
AT (1) ATE155039T1 (de)
AU (1) AU685538B2 (de)
CA (1) CA2138451C (de)
DE (2) DE659432T1 (de)
DK (1) DK0659432T3 (de)
ES (1) ES2105501T3 (de)
FI (1) FI116035B (de)
GR (1) GR3024817T3 (de)
NO (1) NO305273B1 (de)
NZ (1) NZ270228A (de)
ZA (1) ZA949929B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
CA2205897A1 (en) * 1994-11-22 1996-05-30 Malcolm Cecil Pike Compositions and methods for contraception and for treatment of benign gynecological disorders
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
ATE195871T1 (de) * 1997-09-23 2000-09-15 Akzo Nobel Nv Steroid enthaltende dosierungsformen mit einer steroiddichten umhüllung
WO2000074754A2 (en) 1999-06-05 2000-12-14 Innovata Biomed Limited Delivery system
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
CZ20021198A3 (cs) * 1999-10-11 2002-09-11 Ml Laboratories Plc Zařízení pro podávání léčiva s povrchovou úpravou odolnou proti vlhkosti
US6254888B1 (en) 2000-01-28 2001-07-03 Boehringer Ingelheim Pharmaceuticals, Inc. Method for coating pharmaceutical dosage forms
EP1269995A1 (de) * 2000-03-27 2003-01-02 Kyowa Hakko Kogyo Co., Ltd. Einfach einnehmbares granulat
CA2408956C (en) * 2000-05-18 2011-07-12 Therics, Inc. Method and form of a drug delivery device,such as encapsulating a toxic core within a non-toxic region in an oral dosage form
JP2002068965A (ja) * 2000-08-31 2002-03-08 Teikoku Hormone Mfg Co Ltd 単層糖衣錠及びその製造方法
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
EP1744800B1 (de) 2004-04-21 2016-06-22 Innovata Biomed Limited Inhalator
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
ATE478564T1 (de) * 2004-10-15 2010-09-15 Suedzucker Ag Verbessertes trommelcoating-verfahren
JP4808453B2 (ja) * 2005-08-26 2011-11-02 株式会社荏原製作所 研磨方法及び研磨装置
WO2007035961A2 (en) * 2005-09-23 2007-03-29 Threshold Pharmaceuticals, Inc. Anti-cancer therapies
CN103281913A (zh) * 2010-12-29 2013-09-04 雀巢产品技术援助有限公司 包含团聚的油粉的糖果产品
IN2014DN10980A (de) * 2012-07-03 2015-09-18 Nestec Sa
JP2016501854A (ja) * 2012-11-22 2016-01-21 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツングEvonik Roehm GmbH 粉末組成物から顆粒状産物を製造する方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2736682A (en) * 1954-10-11 1956-02-28 Victor M Hermelin Method of making a prolonged action medicinal tablet
US3576663A (en) * 1967-05-29 1971-04-27 Colorcon Coated tablet
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations

Also Published As

Publication number Publication date
FI946043A0 (fi) 1994-12-22
AU8168494A (en) 1995-06-29
US5662936A (en) 1997-09-02
CN1108929A (zh) 1995-09-27
DE69404116D1 (de) 1997-08-14
FI116035B (fi) 2005-09-15
EP0659432A1 (de) 1995-06-28
CA2138451A1 (en) 1995-06-24
KR100330560B1 (ko) 2002-09-05
NZ270228A (en) 1995-09-26
AU685538B2 (en) 1998-01-22
FI946043L (fi) 1995-06-24
NO944991D0 (no) 1994-12-22
DE69404116T2 (de) 1997-11-13
JPH07206681A (ja) 1995-08-08
ES2105501T3 (es) 1997-10-16
NO305273B1 (no) 1999-05-03
CA2138451C (en) 2007-04-24
NO944991L (no) 1995-06-26
KR950016715A (ko) 1995-07-20
GR3024817T3 (en) 1998-01-30
DE659432T1 (de) 1997-01-30
DK0659432T3 (da) 1998-02-16
ATE155039T1 (de) 1997-07-15
EP0659432B1 (de) 1997-07-09

Similar Documents

Publication Publication Date Title
GR3024817T3 (en) Sugar-coated pharmaceutical dosage unit.
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
CA2304770A1 (en) A use of steroidal saponins for the prophylaxis or treatment of dementia, and novel steroidal saponin compounds
AU5587690A (en) Treatment of postmenopausal disorders
HU9603584D0 (en) Sterol derivatives which applicable for regulation of meiosis
UA41909C2 (uk) Використання комбінації сполук для інгібірування остеопорозу, фармацевтичний препарат
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
CA2166332A1 (en) Antiglucocorticoid steroids for the treatment of anxiety disorders
GB9414966D0 (en) Pharmaceutical compositions for the nasal administration of antiviral agents
EP0221728A3 (en) Monosaccharide containing wound healing preparation
ZA941464B (en) Use of pregnane derivative
GR3025872T3 (en) Orally active derivatives of 1,3,5(10)-estratriene
IL109866A (en) Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it
ZA929879B (en) Compositions for the treatment of mammalian diseases.
TW218011B (de)
IL110780A0 (en) Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold
ES2065855A1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
ES8801267A1 (es) Procedimiento para preparar derivados de isoquinolinona
HU9402237D0 (en) Use of benzene-sulfonyl-indol derivatives for producing pharmaceutical compositions
ES2184285T3 (es) Compuestos farmaceuticos que contienen diclorhidrato de cinconina.
AU1067795A (en) Use of lithium compounds in the treatment and prevention of alzheimer's disease